Across TCGA pan-cancer cohorts, NUP210P1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated NUP210P1 data layer compared with 2 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NUP210P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated NUP210P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC, LAML, and BLCA are the cancer types where NUP210P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.758	0.584	.008	33	view →
LAML	DFS	Quartile	All	0.422	0.613	.006	18	view →
BLCA	OS	Tertile	IV	0.141	0.573	.034	9	view →
GBM	DFS	Tertile	All	0.173	0.314	.035	9	view →
LUSC	DFS	Tertile	III,IV	0.181	0.554	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: NUP210P1 tumor-vs-normal RNA expression · all NUP210P1 data types